Get started
Author

Lorna Flanagan

Observed names: Flanagan, Lorna, L Flanagan, L. Flanagan
ORCID: 0000-0001-5616-1055
Observed ORCID: 0000-0001-5616-1055
OpenAlex ID: A5031678435
Paracrine control of tissue regeneration and cell proliferation by Caspase-3
2013 · K Boland, L Flanagan, et al. · Cell Death and Disease · 162
PDF
Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach
2016 · L Flanagan, M Meyer, et al. · Cell Death and Disease · 115
PDF
XIAP impairs Smac release from the mitochondria during apoptosis
2010 · L Flanagan, J Sebastià, et al. · Cell Death and Disease · 63
PDF
BCL-2 system analysis identifies high-risk colorectal cancer patients
2016 · Andreas U Lindner, Manuela Salvucci, et al. · Gut · 51
High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer
2015 · L. Flanagan, J. Kehoe, et al. · Radiation Oncology · 47
PDF
Apoptosis repressor with caspase recruitment domain, a multifunctional modulator of cell death
2010 · Agnieszka H. Ludwig-Galezowska, Lorna Flanagan, et al. · Journal of Cellular and Molecular Medicine · 46
PDF
Proteasome Inhibition Can Impair Caspase-8 Activation upon Submaximal Stimulation of Apoptotic Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Signaling
2012 · Maike A. Laussmann, Egle Passante, et al. · Journal of Biological Chemistry · 42
PDF
Systems Analysis of Cancer Cell Heterogeneity in Caspase-dependent Apoptosis Subsequent to Mitochondrial Outer Membrane Permeabilization
2012 · Jasmin Schmid, Heiko Dussmann, et al. · Journal of Biological Chemistry · 28
PDF
A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2016 · Manuela Salvucci, Maximilian L. Würstle, et al. · Clinical Cancer Research · 26
BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer
2014 · L. Flanagan, A. U. Lindner, et al. · Journal of Molecular Medicine · 25
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant
2015 · Z Zakaria, A Tivnan, et al. · British Journal of Cancer · 17
PDF
Targeting the 19S proteasomal subunit, Rpt4, for the treatment of colon cancer
2016 · Karen Boland, Lorna Flanagan, et al. · European Journal of Pharmacology · 16
Dimerization of Smac is crucial for its mitochondrial retention by XIAP subsequent to mitochondrial outer membrane permeabilization
2011 · Lorna Flanagan, Jordi Sebastia, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 7
PDF
Mislocalization of Mitochondrial Intermembrane Space Proteins
2016 · Lorna Flanagan, Federico Lucantoni, et al. · Springer eBooks · 1
Supplementary Table ST1 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
Supplementary Figure S3 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
PDF
Supplementary Methods SM1 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
Supplementary Methods SM3 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
PDF
Supplementary Figure S2 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
PDF
Supplementary Figure S1 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
PDF
Supplementary Table ST2 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
Supplementary Methods SM2 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
PDF
Data from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
Supplementary Figure S2 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
Supplementary Figure S1 from A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
2023 · Manuela Salvucci, Maximilian L. Würstle, et al.
Works count: 29
Citation count: 646
H-index: 12
I10-index: 12
Year
Topic
Type